{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:02:06Z","timestamp":1784613726637,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031900","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T17:51:30Z","timestamp":1329846690000},"page":"e31900","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)"],"prefix":"10.1371","volume":"7","author":[{"given":"Neil","family":"Auricchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan D.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1002\/9783527630073","article-title":"Tuberous sclerosis complex","author":"DJ Kwiatkowski","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.","volume":"412","author":"J Huang","year":"2008","journal-title":"Biochem J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer.","volume":"12","author":"DA Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing.","volume":"12","author":"R Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00109-011-0726-6","article-title":"mTOR links oncogenic signaling to tumor cell metabolism.","volume":"89","author":"JL Yecies","year":"2011","journal-title":"J Mol Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.","volume":"14 Spec No. 2","author":"DJ Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.","volume":"59","author":"DN Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.","volume":"363","author":"DA Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis.","volume":"364","author":"FX McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","article-title":"Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.","volume":"29","author":"U Ozcan","year":"2008","journal-title":"Mol Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1158\/1535-7163.MCT-09-0239","article-title":"The relationship among tumor architecture, pharmacokinetics, pharmacodynamics, and efficacy of bortezomib in mouse xenograft models.","volume":"8","author":"MJ Williamson","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ncponc0555","article-title":"Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.","volume":"3","author":"T Caravita","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1101\/gad.1199104","article-title":"Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.","volume":"18","author":"MN Corradetti","year":"2004","journal-title":"Genes Dev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling.","volume":"6","author":"RJ Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint.","volume":"30","author":"DM Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival.","volume":"115","author":"K Inoki","year":"2003","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.","volume":"310","author":"RJ Shaw","year":"2005","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","article-title":"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.","volume":"154","author":"WL Bennett","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","article-title":"Metformin prevents tobacco carcinogen\u2013induced lung tumorigenesis.","volume":"3","author":"RM Memmott","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20080557","article-title":"Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.","volume":"412","author":"X Huang","year":"2008","journal-title":"Biochem J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.","volume":"104","author":"H Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-8-38","article-title":"Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.","volume":"8","author":"K Pollizzi","year":"2009","journal-title":"Mol Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13255","DOI":"10.1074\/jbc.272.20.13255","article-title":"Contraction-induced changes in acetyl-CoA carboxylase and 5\u2032-AMP-activated kinase in skeletal muscle.","volume":"272","author":"D Vavvas","year":"1997","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1074\/jbc.M109.072694","article-title":"Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation.","volume":"285","author":"C Li","year":"2010","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.","volume":"42","author":"L Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.","volume":"57","author":"H Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"ref28","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.","volume":"61","author":"T Hideshima","year":"2001","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation.","volume":"334","author":"P Walter","year":"2011","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1940-6207.CAPR-10-0178","article-title":"Chemoprevention meets glucose control.","volume":"3","author":"JA Engelman","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref31","first-page":"455","article-title":"A mathematical model for tumor volume evaluation using two-dimensions.","volume":"4","author":"JP Feldman","year":"2009","journal-title":"J Appl Quant Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:20:06Z","timestamp":1540261206000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031900"}},"subtitle":[],"editor":[{"given":"Ashraf B.","family":"Abdel-Naim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031900","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]}}}